Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement
- 31 December 2007
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 31 (6) , 825-831
- https://doi.org/10.1016/j.neubiorev.2007.05.007
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Convergent Functional Genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkersNeuroscience & Biobehavioral Reviews, 2007
- Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2007
- Mania-like behavior induced by disruption of CLOCKProceedings of the National Academy of Sciences, 2007
- Circadian genes, rhythms and the biology of mood disordersPharmacology & Therapeutics, 2007
- A reverse-translational approach to bipolar disorder: Rodent and human studies in the Behavioral Pattern MonitorNeuroscience & Biobehavioral Reviews, 2007
- The behavioral actions of lithium in rodent models: Leads to develop novel therapeuticsNeuroscience & Biobehavioral Reviews, 2007
- GSK-3 is a viable potential target for therapeutic intervention in bipolar disorderNeuroscience & Biobehavioral Reviews, 2007
- Association of Genetic Risks for Schizophrenia and Bipolar DisorderWith Specific and Generic Brain Structural EndophenotypesArchives of General Psychiatry, 2004
- Neuroprotective and Neurotrophic Actions of the Mood Stabilizer Lithium: Can It Be Used to Treat Neurodegenerative Diseases?Critical Reviews™ in Neurobiology, 2004
- Costs of Bipolar DisorderPharmacoEconomics, 2003